Contact: Elizabeth A. Harris
For more information, please contact our blog editors directly or use the form below.
Emily Chi Fogler
Phone: 617-603-1071
Email: efogler@ebglaw.com
Amy Lerman
Phone: 202-861-1832
Email: alerman@ebglaw.com
Blog Editors
Recent Updates
- FDA Proposal Would Leave Semaglutide, Tirzepatide, and Liraglutide Off 503B Bulks List
- The DOJ’s Bulk Sensitive Data Rule and Your Obligation to “Know Your Reporting Requirements”
- Is Your Product Ready to Be Listed? What the Dietary Supplement Listing Act of 2026 Means for Your Business
- New York’s Food Safety and Chemical Disclosure Act: A State-Level Overhaul of GRAS Regulation
- Fighting Fire with Fire: Project Glasswing and AI-Powered Cyber Defense in Health Care, Financial Health and Other Critical Infrastructure